Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADSS2 | P30520 | 2/20 | 1.00 |
| ▸ | PYGB | P11216 | 4/20 | 0.57 |
| ▸ | PYGL | P06737 | 3/20 | 0.57 |
| ▸ | PYGM | P11217 | 2/20 | 0.57 |
| ▸ | FBP1 | P09467 | 1/20 | 0.45 |
| ▸ | UMPS | P11172 | 2/20 | 0.35 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.35 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
| ▸ | IGF2R | P11717 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydantocidin SCHEMBL10339110 | 0.77 | PYGB (0.90) | ADSS2PYGBPYGLPYGM | |
| SCHEMBL9736981 | 0.69 | ADSS2 (0.52) | ADSS2FBP1DNPH1IGF2R | |
| Fructose 1,6-Diphosphate SCHEMBL168245 | 0.69 | ADSS2 (0.52) | ADSS2FBP1UMPSIGF2R | |
| SCHEMBL8056 | 0.69 | ADSS2 (0.52) | ADSS2FBP1DNPH1IGF2R | |
| Fructose 1,6-Diphosphate SCHEMBL19133126 | 0.69 | ADSS2 (0.52) | ADSS2FBP1UMPSIGF2R | |
| SCHEMBL1493046 | 0.69 | ADSS2 (0.52) | ADSS2FBP1DNPH1IGF2R | |
| SCHEMBL2591882 | 0.69 | ADSS2 (0.52) | ADSS2FBP1DNPH1IGF2R | |
| Fructose 1,6-Diphosphate SCHEMBL14905889 | 0.69 | ADSS2 (0.52) | ADSS2FBP1UMPSIGF2R | |
| Fructose 1,6-Diphosphate SCHEMBL166666 | 0.69 | ADSS2 (0.52) | ADSS2FBP1UMPSIGF2R | |
| Fosfructose SCHEMBL20731194 | 0.69 | ADSS2 (0.52) | ADSS2FBP1UMPSIGF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177312-A2 | INHIBITOR OF CELLULAR PURINE NUCLEOTIDE SALVAGE PATHWAY ENZYME FOR USE IN THE TREATMENT AND/OR PREVENTION OF HELICOBACTER PYLORI INFECTION AND/OR DISEASE ASSOCIATED WITH SUCH INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | UNIWERSYTET WARSZAWSKI (PL) | 2023-09-21 | — | — | WO | claimed |
| WO-2023177312-A2 | INHIBITOR OF CELLULAR PURINE NUCLEOTIDE SALVAGE PATHWAY ENZYME FOR USE IN THE TREATMENT AND/OR PREVENTION OF HELICOBACTER PYLORI INFECTION AND/OR DISEASE ASSOCIATED WITH SUCH INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | UNIWERSYTET WARSZAWSKI (PL) | 2023-09-21 | — | — | WO | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-8036831-B2 | Ligand searching device, ligand searching method, program, and recording medium | IN-SILICO SCIENCES, INC. (JP) | 2011-10-11 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-20070166760-A1 | Ligand searching device, ligand searching method, program, and recording medium | IN-SILICO SCIENCES, INC. | 2007-07-19 | — | — | US | disclosed |
| EP-1724697-A1 | LIGAND SEARCHING DEVICE, LIGAND SEARCHING METHOD, PROGRAM, AND RECORDING MEDIUM | In-Silico Sciences, Inc. (JP) | 2006-11-22 | — | — | EP | disclosed |